Drug offers hope in treating ocular melanoma

Video

Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.

The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.

Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Related Content
Pawan Singh, PhD, assistant professor in the University of Missouri School of Medicine. Image credit: University of Missouri

Molecules in aqueous humor may lead to biomarker discovery for glaucoma, according to study

Jordana Joy, Associate Editor
August 23rd 2025
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
August 23rd 2025
Podcast
Tubulointerstitial nephritis and uveitis- A multidisciplinary approach to diagnosing a rare disease - Image credit: ©Halfpoint—stock.adobe.com

Tubulointerstitial nephritis and uveitis: A multidisciplinary approach to diagnosing a rare disease

Lynda Charters
August 23rd 2025
Article
Advances in treatment for geographic atrophy

Advances in treatment for geographic atrophy

David S. Boyer, MD;Tina Mac Donald, OD, CDCES, FAAO;Leo P. Semes, OD, FAAO
August 23rd 2025
Podcast
Physician conducting OCT exam on patient Image credit: AdobeStock/MariaVitkovska

Exploratory analysis discovers key predictive factors of improved BCVA in treatment of LHON disease with lenadogene nolparvovec

Jordana Joy, Associate Editor
August 23rd 2025
Article
Retinal microvasculature on OCTA may predict coronary artery disease risk - Image credit: ©H_Ko—stock.adobe.com

Retinal microvasculature on OCTA may predict coronary artery disease risk

Lynda Charters
August 23rd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.